How many employees does Palvella Therapeutics, Inc. have?

Palvella Therapeutics, Inc. reported 127 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 31, 2023. That is up 2.4% from a year earlier.

What is Palvella Therapeutics, Inc.'s revenue per employee?

Palvella Therapeutics, Inc. brought in $25.9M of revenue in fiscal Dec 2022, which is $204K per employee. That ranks 80 of 109 companies we track in Biotechnology, where the median is $458K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Palvella Therapeutics, Inc. employees and revenue per employee

PVLA · Biotechnology · $1.99B market cap

Palvella Therapeutics, Inc. had 127 employees at the end of fiscal Dec 2022, up 2.4% from a year earlier. Revenue for the year was $25.9M, down 17.6% from a year earlier, or $204K per employee. Revenue fell while headcount grew.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

127

+2.4% YoY

Revenue

$25.9M

-17.6% YoY

Revenue / employee

$204K

Peer median $458K

Rank in industry

80 of 109

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2021

Hover a year for the numbers.

PVLA employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2022	127	$25.9M	$204K	+2.4%	-17.6%
Dec 2021	124	$31.4M	$253K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Palvella Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
FENC Fennec Pharmaceuticals Inc.	35	$44.6M	$1.28M	Hiring into decline
OBIO Orchestra BioMed Holdings, Inc.	86	$33.5M	$389K	Efficient growth
SEPN Septerna Inc	130	$46.0M	$353K	Efficient growth
VSTM Verastem, Inc.	102	$30.9M	$303K	Efficient growth
PVLA Palvella Therapeutics, Inc.	127	$25.9M	$204K	Hiring into decline
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
CAPR Capricor Therapeutics, Inc.	160	$22.3M	$139K	Hiring into decline
ALMS Alumis Inc.	221	$24.1M	$109K	—
RLAY Relay Therapeutics, Inc.	192	$15.4M	$80K	Leaner

Every Healthcare company

Questions about Palvella Therapeutics, Inc.

How many employees does Palvella Therapeutics, Inc. have?: Palvella Therapeutics, Inc. reported 127 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 31, 2023. That is up 2.4% from a year earlier.
What is Palvella Therapeutics, Inc.'s revenue per employee?: Palvella Therapeutics, Inc. brought in $25.9M of revenue in fiscal Dec 2022, which is $204K per employee. That ranks 80 of 109 companies we track in Biotechnology, where the median is $458K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare PVLA with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Palvella Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 31, 2023. This is data, not a recommendation to buy or sell PVLA.